Hospital Pharmacy Europe - Cardiovascular medicine,

Click here

Thursday 23 May 2013 Register Login

You are here:

Suppliers Guide

New neurology product

Hospital Pharmacy Europe is assisting with a survey on messaging for a new neurology product. Click here

LATEST ISSUE

Contamination control and preparation of anticancer drugs, medicines reconciliation, Ruconest drug evaluation, ivacaftor for cystic fibrosis , oxycodone-naloxone prolonged-release tablets, IV chemotherapy, capsaicin in the treatment of severe neuropathic pain, alitretinoin in severe chronic hand eczema, Zyclara for actinic keratoses

Pharmacy Zone: Cardiovascular medicine

Magazine	Sponsored content
News	Video

Page:

3

Thu 6 Sep
2012

Personalised dosing
A follow-up subanalysis of the most influential atrial-fibrillation (AF) trial of dabigatran etexilate (Pradaxa, Boehringer...

Fri 31 Aug
2012

Arrhythmia treatment gaps
An ESC analysis of arrhythmia treatments during 2008-2012 has revealed large treatment gradients from West to East, with Eastern...

Fri 31 Aug
2012

FFR-guided cardiac stenting
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, has announced results of the FAME II Trial demonstrating that...

Wed 29 Aug
2012

German aortic valve registry
The German Aortic Valve Registry (GARY) was started in July 2010 and is the only registry so far to include both transcatheter...

Wed 29 Aug
2012

Inspra® reduces risk of recurrent heart failure hospitalisation
Pfizer Inc. has announced results from a new post-hoc analysis of the EMPHASIS-HF trial showing statistically significant...

Wed 29 Aug
2012

Label extension for Gadovist® 1.0
Bayer HealthCare’s Medical Care division has completed the European variation procedure for Gadovist®1.0 (gadobutrol)...

Tue 28 Aug
2012

Cost effectiveness and clinical efficacy of Pradaxa®
In the absence of a head-to-head study, a comprehensive analysis published in Thrombosis and Hemostasis,(1) looks into the...

Tue 28 Aug
2012

European launch of next-generation XIENCE Xpedition™ Drug eluting stent
Abbott has announced that the XIENCE Xpedition™ Everolimus Eluting Coronary Stent System received CE Mark in Europe for the...

Tue 28 Aug
2012

CRT consensus
The 2012 Expert Consensus Statement on Cardiac Resynchronisation Therapy (CRT) in Heart Failure: Implant and Follow-up...

Thu 23 Aug
2012

Non-valvular atrial fibrillation
Bayer HealthCare has announced the initiation of two new studies investigating its once-daily, oral anticoagulant Xarelto®...

Wed 22 Aug
2012

Gore gains EU approval for vascular graft
W. L. Gore & Associates has received CE Mark for the Gore Hybrid Vascular Graft, which is designed to expand treatment...

Mon 20 Aug
2012

Latest Xarelto® (Rivaroxaban) data to be presented at ESC

Thu 2 Aug
2012

Birmingham hospitals named Exemplar VTE centre
University Hospitals Birmingham named Exemplar Centre for venous thromboembolism in recognition of excellent work in the field

Mon 25 Jun
2012

Trimetazidine backing restricted to angina add-on
EMA restricted trimetazidine drug recommendation to secone-line therapy of angina pectoris

Fri 22 Jun
2012

FDA responds to Xarelto® sNDA for second prevention
The Agency has responded to the sNDA for Xarelto® for prevention of secondary events in ACS patients

Thu 21 Jun
2012

Short-term antiarrhythmics avert relapse
A Lancet trial demonstrates that four weeks' therapy can cut 80% of relapses avoided with long-term therapy

Wed 20 Jun
2012

Pradaxa® benefits anticoagulation in AF
Pradaxa® was associated with a shorter anticoagulation interruption than warfarin in AF patients requiring surgery

Tue 19 Jun
2012

COMP adopts applications for four lipodystrophy drugs
Committee for Orphan Medicinal Products adopted four designation applications for rare lipodystrophy forms

Wed 6 Jun
2012

Xarelto® backed by NICE draft guidance
Rivaroxaban recommended as single drug therapy for treatment DVT and prevention recurrent DVT and PE

Fri 1 Jun
2012

BI partners ammado for 1 mission 1 million
Boehringer Ingelheim has announced a partnership with fundraising expert ammado for the AF cause

Page:

3

Web design, hosting and programming by ModeZero